Polymer Capital Management (US) LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1973324
NEW YORK, NY
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$649,492
New position
Shares Held
1,940
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#191
of 306 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polymer Capital Management (US) LLC holds $5,718,267 across 19 Biotechnology names. PRAX ranks #2 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
|
7,607 | $795,844 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
1,940 | $649,492 | |
| 3 | RPRX |
Royalty Pharma plc
|
9,552 | $535,580 | |
| 4 | MRNA |
Moderna, Inc.
|
7,002 | $490,350 | |
| 5 | INSM |
INSMED Inc
|
4,537 | $483,734 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
772 | $481,372 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,056 | $438,326 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,415 | $425,957 |
All Filings in PRAX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $649,492 | 1,940 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||